These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24566984)

  • 1. Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.
    Camorani S; Esposito CL; Rienzo A; Catuogno S; Iaboni M; Condorelli G; de Franciscis V; Cerchia L
    Mol Ther; 2014 Apr; 22(4):828-41. PubMed ID: 24566984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
    Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
    Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
    Camorani S; Passariello M; Agnello L; Esposito S; Collina F; Cantile M; Di Bonito M; Ulasov IV; Fedele M; Zannetti A; De Lorenzo C; Cerchia L
    J Exp Clin Cancer Res; 2020 Sep; 39(1):180. PubMed ID: 32892748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
    Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
    Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.
    Akhavan D; Pourzia AL; Nourian AA; Williams KJ; Nathanson D; Babic I; Villa GR; Tanaka K; Nael A; Yang H; Dang J; Vinters HV; Yong WH; Flagg M; Tamanoi F; Sasayama T; James CD; Kornblum HI; Cloughesy TF; Cavenee WK; Bensinger SJ; Mischel PS
    Cancer Discov; 2013 May; 3(5):534-47. PubMed ID: 23533263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer.
    Camorani S; Hill BS; Fontanella R; Greco A; Gramanzini M; Auletta L; Gargiulo S; Albanese S; Lucarelli E; Cerchia L; Zannetti A
    Theranostics; 2017; 7(14):3595-3607. PubMed ID: 28912898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells.
    Esposito CL; Nuzzo S; Kumar SA; Rienzo A; Lawrence CL; Pallini R; Shaw L; Alder JE; Ricci-Vitiani L; Catuogno S; de Franciscis V
    J Control Release; 2016 Sep; 238():43-57. PubMed ID: 27448441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes.
    Ruan J; Luo M; Wang C; Fan L; Yang SN; Cardenas M; Geng H; Leonard JP; Melnick A; Cerchietti L; Hajjar KA
    Blood; 2013 Jun; 121(26):5192-202. PubMed ID: 23632889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.
    Esposito CL; Nuzzo S; Catuogno S; Romano S; de Nigris F; de Franciscis V
    Mol Ther Nucleic Acids; 2018 Mar; 10():398-411. PubMed ID: 29499951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death.
    Esposito CL; Passaro D; Longobardo I; Condorelli G; Marotta P; Affuso A; de Franciscis V; Cerchia L
    PLoS One; 2011; 6(9):e24071. PubMed ID: 21915281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.
    Pfister C; Pfrommer H; Tatagiba MS; Roser F
    Br J Cancer; 2012 Nov; 107(10):1702-13. PubMed ID: 23047550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells.
    Kaulfuß S; Seemann H; Kampe R; Meyer J; Dressel R; König B; Scharf JG; Burfeind P
    Oncotarget; 2013 Jul; 4(7):1037-49. PubMed ID: 23900414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.
    Xu L; Tong R; Cochran DM; Jain RK
    Cancer Res; 2005 Jul; 65(13):5711-9. PubMed ID: 15994946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-PDGFRβ aptamer for selective delivery of small therapeutic peptide to cardiac cells.
    Romanelli A; Affinito A; Avitabile C; Catuogno S; Ceriotti P; Iaboni M; Modica J; Condorelli G; Catalucci D
    PLoS One; 2018; 13(3):e0193392. PubMed ID: 29513717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma.
    Wang F; Remke M; Bhat K; Wong ET; Zhou S; Ramaswamy V; Dubuc A; Fonkem E; Salem S; Zhang H; Hsieh TC; O'Rourke ST; Wu L; Li DW; Hawkins C; Kohane IS; Wu JM; Wu M; Taylor MD; Wu E
    Oncotarget; 2015 Feb; 6(5):2709-24. PubMed ID: 25576913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific targeting of PDGFRβ in the stroma inhibits growth and angiogenesis in tumors with high PDGF-BB expression.
    Tsioumpekou M; Cunha SI; Ma H; Åhgren A; Cedervall J; Olsson AK; Heldin CH; Lennartsson J
    Theranostics; 2020; 10(3):1122-1135. PubMed ID: 31938055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of PDGF-B aptamer on PDGFRβ/PDGF-B interaction: Molecular dynamics study.
    Vu CQ; Rotkrua P; Soontornworajit B; Tantirungrotechai Y
    J Mol Graph Model; 2018 Jun; 82():145-156. PubMed ID: 29738888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gint4.T-Modified DNA Tetrahedrons Loaded with Doxorubicin Inhibits Glioma Cell Proliferation by Targeting PDGFRβ.
    Wang F; Zhou Y; Cheng S; Lou J; Zhang X; He Q; Huang N; Cheng Y
    Nanoscale Res Lett; 2020 Jul; 15(1):150. PubMed ID: 32691170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosines-740/751 of PDGFRβ contribute to the activation of Akt/Hif1α/TGFβ nexus to drive high glucose-induced glomerular mesangial cell hypertrophy.
    Das F; Ghosh-Choudhury N; Kasinath BS; Choudhury GG
    Cell Signal; 2018 Jan; 42():44-53. PubMed ID: 28951244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.